The results showed that the most common mutations in HER2-low BC were PIK3CA (31/99, 31%), GATA3 (18/99, 18%), TP53 (17/99, 17%), and ERBB2 (8/99, 8%). This evidence concerns the gene TP53 and breast cancer.